Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Up 1.2% – Still a Buy?

Posted by Grant Hamersma on May 27th, 2026

Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) shot up 1.2% during mid-day trading on Tuesday . The stock traded as high as $30.74 and last traded at $30.72. 7,201 shares were traded during trading, an increase of 38% from the average session volume of 5,222 shares. The stock had previously closed at $30.36.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Zacks Research raised shares of Carl Zeiss Meditec to a “hold” rating in a research note on Friday, April 24th. Sanford C. Bernstein cut shares of Carl Zeiss Meditec to a “market perform” rating in a research note on Monday, January 26th. One investment analyst has rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Carl Zeiss Meditec presently has a consensus rating of “Hold”.

Check Out Our Latest Analysis on CZMWY

Carl Zeiss Meditec Stock Up 1.2%

The firm’s fifty day moving average price is $29.83 and its 200 day moving average price is $37.46.

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.